Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-02-14 08:55 am Unchanged | 2023-12-31 | 13G | Silence Therapeutics plc SLN | Deep Track Capital, LP | 5,854,740 5.430% | 0 (Unchanged) | Filing History |
| 2024-02-14 08:54 am Purchase | 2023-12-31 | 13G | Repare Therapeutics Inc. RPTX | Deep Track Capital, LP | 2,992,731 7.100% | 265,125 (+9.72%) | Filing History |
| 2024-02-14 08:53 am Sale | 2023-12-31 | 13G | Relmada Therapeutics, Inc. RLMD | Deep Track Capital, LP | 2,044,507 6.790% | -793,311 (-27.95%) | Filing History |
| 2024-02-14 08:52 am Sale | 2023-12-31 | 13G | RAPT Therapeutics, Inc. RAPT | Deep Track Capital, LP | 224,246 5.220% | -24,680 (-9.91%) | Filing History |
| 2024-02-14 08:52 am Purchase | 2023-12-31 | 13G | Pliant Therapeutics, Inc. PLRX | Deep Track Capital, LP | 5,750,000 9.600% | 2,645,493 (+85.21%) | Filing History |
| 2024-02-14 08:51 am Purchase | 2023-12-31 | 13G | Nurix Therapeutics, Inc. NRIX | Deep Track Capital, LP | 2,997,830 6.180% | 280,659 (+10.33%) | Filing History |
| 2024-02-14 08:50 am Purchase | 2023-12-31 | 13G | Nektar Therapeutics NKTR | Deep Track Capital, LP | 1,226,667 9.650% | 406,518 (+49.57%) | Filing History |
| 2024-02-14 08:50 am Sale | 2023-12-31 | 13G | Jounce Therapeutics, Inc. JNCE | Deep Track Capital, LP | 0 0.000% | -4,259,653 (Position Closed) | Filing History |
| 2024-02-14 08:49 am Sale | 2023-12-31 | 13G | IVERIC bio, Inc. ISEE | Deep Track Capital, LP | 0 0.000% | -7,878,119 (Position Closed) | Filing History |
| 2024-02-14 08:48 am Sale | 2023-12-31 | 13G | Inozyme Pharma, Inc. INZY | Deep Track Capital, LP | 0 0.000% | -3,250,000 (Position Closed) | Filing History |
| 2024-02-14 08:47 am Sale | 2023-12-31 | 13G | Immunovant, Inc. IMVT | Deep Track Capital, LP | 1,000,000 0.690% | -8,710,000 (-89.70%) | Filing History |
| 2024-02-14 08:47 am Sale | 2023-12-31 | 13G | Immunic, Inc. IMUX | Deep Track Capital, LP | 0 0.000% | -4,022,989 (Position Closed) | Filing History |
| 2024-02-14 08:46 am Sale | 2023-12-31 | 13G | Heron Therapeutics, Inc. HRTX | Deep Track Capital, LP | 0 0.000% | -12,232,267 (Position Closed) | Filing History |
| 2024-02-14 08:45 am Unchanged | 2023-12-31 | 13G | HilleVax, Inc. HLVX | Deep Track Capital, LP | 2,900,000 5.990% | 0 (Unchanged) | Filing History |
| 2024-02-14 08:45 am Sale | 2023-12-31 | 13G | Structure Therapeutics Inc. GPCR | Deep Track Capital, LP | 900,000 0.660% | -7,040,346 (-88.67%) | Filing History |
| 2024-02-14 08:44 am Purchase | 2023-12-31 | 13G | Geron Corporation GERN | Deep Track Capital, LP | 29,583,449 5.450% | 5,560,566 (+23.15%) | Filing History |
| 2024-02-14 08:43 am Sale | 2023-12-31 | 13G | 4D Molecular Therapeutics, Inc. FDMT | Deep Track Capital, LP | 2,284,372 5.340% | -372,529 (-14.02%) | Filing History |
| 2024-02-14 08:43 am Sale | 2023-12-31 | 13G | Edgewise Therapeutics, Inc. EWTX | Deep Track Capital, LP | 2,537,176 4.000% | -837,218 (-24.81%) | Filing History |
| 2024-02-14 08:42 am Sale | 2023-12-31 | 13G | Esperion Therapeutics, Inc. ESPR | Deep Track Capital, LP | 0 0.000% | -6,345,790 (Position Closed) | Filing History |
| 2024-02-14 08:40 am Purchase | 2023-12-31 | 13G | Editas Medicine, Inc. EDIT | Deep Track Capital, LP | 5,473,086 6.700% | 979,670 (+21.80%) | Filing History |